ClinicalTrials.gov
public full text
Public Domain
Food Study of Letrozole Tablets 2.5 mg and Femara® Tablets 2.5 mg
The objective of this study was to investigate the bioequivalence of Mylan's letrozole 2.5 mg tablets to Novartis' Femara® 2.5 mg tablets following a single, oral 2.5 mg (1 x 2.5 mg) dose administered under fed conditions.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Bioequivalence Study of Letrozole 2.5 mg Tablets#1032948
- A Study in Healthy People to Compare 2 Different Formulations of Nerandomilast Tablets When Taken With or Without Food#1211585
- Cilostazol 100 mg Tablet Formulations Under Fasting Conditions#1245516
- Individualisation of Voriconazole Antifungal Therapy Antifungal Therapy#1095281
- Leflunomide 20 mg Tablets Under Fasting Conditions#897384
Record · ID 1339991
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive